Index of medicine substances

Estradiol + drospirenone  •  Genito urinary system and sex hormones | Progestogens and estrogens in combination | Progestogens and estrogens, fixed combinations (G03FA17)

Estradiol + dydrogesterone  •  Genito urinary system and sex hormones | Progestogens and estrogens in combination | Progestogens and estrogens, sequential preparations (G03FB08)

Estradiol + levonorgestrel  •  Genito urinary system and sex hormones | Estrogens | Natural and semisynthetic estrogens, plain (G03CA53)

Estradiol + norethisterone  •  Genito urinary system and sex hormones | Progestogens and estrogens in combination | Progestogens and estrogens, fixed combinations (G03FA01)

Estradiol + norgestrel  •  Genito urinary system and sex hormones | Progestogens and estrogens in combination | Progestogens and estrogens, sequential preparations (G03FB01)

Estramustine  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents (L01XX11)

Estriol  •  Genito urinary system and sex hormones | Estrogens | Natural and semisynthetic estrogens, plain (G03CA04)

Etamsylate  •  Blood and blood forming organs | Vitamin k and other hemostatics | Other systemic hemostatics (B02BX01)

Etanercept  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors (L04AB01)

Etelcalcetide  •  Systemic hormonal preparations, excluding sex hormones and insulins | Anti-parathyroid agents | Other anti-parathyroid agents (H05BX04)

Eteplirsen  •  Musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system | Other drugs for disorders of the musculo-skeletal system (M09AX06)

Ethambutol  •  Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Other drugs for treatment of tuberculosis (J04AK02)

Ethinylestradiol + cyproterone  •  Genito urinary system and sex hormones | Antiandrogens | Antiandrogens and estrogens (G03HB01)

Ethinylestradiol + drospirenone  •  Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations (G03AA12)

Ethinylestradiol + levonorgestrel  •  Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations (G03AA07)

Ethionamide  •  Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Thiocarbamide derivatives (J04AD03)

Ethosuximide  •  Nervous system | Antiepileptics | Antiepileptics | Succinimide derivatives (N03AD01)

Ethyl loflazepate  •  Nervous system | Anxiolytics | Benzodiazepine derivatives (N05BA18)

Etifoxin  •  Nervous system | Anxiolytics | Other anxiolytics (N05BX03)

Etilefrine  •  Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Adrenergic and dopaminergic agents (C01CA01)

Etodolac  •  Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Acetic acid derivatives and related substances (M01AB08)

Etofenamat  •  Musculo-skeletal system | Topical products for joint and muscular pain | Topical products for joint and muscular pain | Antiinflammatory preparations, non-steroids for topical use (M02AA06)

Etomidate  •  Nervous system | Anesthetics | Anesthetics, general | Other general anesthetics (N01AX07)

Etonogestrel  •  Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens (G03AC08)

Etonogestrel + ethinylestradiol  •  Genito urinary system and sex hormones | Contraceptives for topical use | Intravaginal contraceptives (G02BB01)

Etoposide  •  Antineoplastic and immunomodulating agents | Plant alkaloids and other natural products | Podophyllotoxin derivatives (L01CB01)

Etoricoxib  •  Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Coxibs (M01AH05)

Etrasimod  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Sphingosine-1-phosphate (S1P) receptor modulators (L04AE05)

Etravirine  •  Antiinfectives for systemic use | Direct acting antivirals | Non-nucleoside reverse transcriptase inhibitors (J05AG04)

Eucalyptus  •  Respiratory system | Expectorants, excl. combinations with cough suppressants (R05CA13)